For many brands, 2023 promises to be an uncertain and unpredictable time. Financial instability is at an all-time high, third-party cookies are on their way out, and consumers are demanding more from brands than ever before. As marketers we’re having to be more sustainable, more relatable, and more accessible – which is making it increasingly harder to control what can only be described as ‘chaos’.

With ChatGPT becoming a major topic of conversation, it’s sparking many existential questions on the role of AI in advertising (and no, AI didn’t write this article — we’re not out to trick you). The focus of the debate seems to come back to the creative realm, however: if we look at content creation and copywriting as an art form, is it ethical to leverage AI to spearhead creative output?

Google wants businesses to up their game by installing Consent Mode on their website – which has left many asking why? But we shouldn’t be asking why, we should be asking why not.  

One of the most awaited features for ecommerce clients, GA4, now offers different item-scoped and event-scoped versions of each ecommerce metric. This enables you to analyze information about your products or services, as well other important ecommerce interactions.

We’re in an era where technology is advancing faster than ever, and artificial intelligence (AI) and automation are leading the way for consumers and marketers alike. With ChatGPT (and the subsequent retaliation of Google Bard) thrusting AI into mainstream media, many have since started questioning the role that intelligent solutions play – and what it means for the future of digital marketing.

We’re delighted to announce that full-service analytics consultants Blue Walrus have joined the Incubeta family alongside our previous acquisitions, Groundswell, Maze-One,  Panalysis, Extendo and Bruce Clay MENA. The acquisition of Blue Walrus will allow our US market to grow their data and analytics proposition, while onboarding Blue Walrus’s extensive list of clients. Including brands such as: Skechers, Boston Scientific, Netspend and Dexcare.